Autolus Stock Rises After Analyst Boosts Price Target
Autolus Therapeutics stock rose 8.1% on Monday. This happened after Needham analyst Gil Blum raised his price target from $10 to $11 and kept a...
US Markets
Get comprehensive coverage of US Markets, including latest updates, analysis, insights, and expert commentary.
U.S. Stock market: Nuvectis Pharma declined by 40.58% while Sow Good was down by 55.30% during mid day trading
Nuvectis Pharma, Inc. fell -40.58%, priced at 6.34 USD with a market cap of 122.495 million USD.